Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 167 Total
MRIN - Marin Software Inc - Stock Price Chart
TickerMRIN [NASD]
CompanyMarin Software Inc
CountryUSA
IndustrySoftware - Application
Market Cap7.46MEPS (ttm)-6.24
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y29.51%
P/S0.43EPS next 5Y20.00%
P/B0.66EPS Q/Q60.40%
Dividend-Sales Q/Q-12.04%
Insider Own7.64%Inst Own9.74%
Insider Trans0.00%Inst Trans-
Short Float1.73%EarningsMay 02/a
Analyst Recom3.00Target Price2.00
Avg Volume954.09K52W Range1.44 - 5.45
Marin Software, Inc. is a cloud-based digital advertising management company. It provides a cross-channel, cross-device, enterprise marketing software platform for search, social, and display advertising channels, offered as a software-as-a-service. The firm's integrated platform is an analytics, workflow, and optimization solution for marketing professionals to manage digital advertising spend across search and display advertising channels. The company was founded by Christopher A. Lien, Paul M. Butler, Joseph Chang, and Wister Walcott on March 16, 2006 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CROVITZ L GORDONDirectorApr 05 '24Option Exercise0.0054,0320189,919Apr 11 05:11 PM
Hutchison Donald P.DirectorApr 05 '24Option Exercise0.0054,0320189,919Apr 11 05:12 PM
Middleton DainaDirectorApr 05 '24Option Exercise0.0054,0320217,891Apr 11 05:13 PM
Mann Diena LeeDirectorApr 05 '24Option Exercise0.0060,8190112,461Apr 11 05:14 PM
Kinion Brian KDirectorApr 05 '24Option Exercise0.0054,0320202,891Apr 11 05:15 PM
RCAT - Red Cat Holdings Inc - Stock Price Chart
TickerRCAT [NASD]
CompanyRed Cat Holdings Inc
CountryUSA
IndustryComputer Hardware
Market Cap83.94MEPS (ttm)-0.51
P/E-EPS this Y44.00%
Forward P/E-EPS next Y57.14%
PEG-EPS past 5Y-
P/S6.11EPS next 5Y-
P/B1.69EPS Q/Q5.56%
Dividend-Sales Q/Q88.24%
Insider Own30.12%Inst Own20.54%
Insider Trans0.00%Inst Trans3.30%
Short Float0.58%EarningsMar 18/a
Analyst Recom1.00Target Price5.00
Avg Volume591.05K52W Range0.52 - 1.65
Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the following segments: Enterprise and Consumer segments. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Evans Allan ThomasCOO, Red Cat Holdings, Inc.Sep 27 '23Buy0.9610,0009,6501,443,945Sep 27 04:01 PM
GSIT - GSI Technology Inc - Stock Price Chart
TickerGSIT [NASD]
CompanyGSI Technology Inc
CountryUSA
IndustrySemiconductors
Market Cap74.89MEPS (ttm)-0.80
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.44EPS next 5Y10.00%
P/B1.89EPS Q/Q-6.42%
Dividend-Sales Q/Q-4.26%
Insider Own30.04%Inst Own17.12%
Insider Trans0.00%Inst Trans-1.54%
Short Float5.73%EarningsMay 02/a
Analyst Recom2.50Target Price8.00
Avg Volume592.12K52W Range1.51 - 9.80
Today 06:13AM Q4 2024 GSI Technology Inc Earnings Call (Thomson Reuters StreetEvents) -19.78%
May-02-24 09:56PM GSIT Stock Earnings: GSI Technology Reported Results for Q4 2024 (InvestorPlace) -6.11%
05:45PM GSI Technology: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM GSI Technology, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results and Business Update (GlobeNewswire)
Apr-18-24 08:55AM GSI Technology to Announce Fiscal Fourth Quarter and Year End 2024 Results on May 2, 2024 (GlobeNewswire)
Apr-02-24 08:55AM GSI Technology Announces Production Release of Two Gemini-I APU Servers (GlobeNewswire) +35.09%
Mar-31-24 12:15PM 10 AI Stocks That Will Skyrocket (Insider Monkey)
Jan-27-24 09:24AM GSI Technology, Inc. (NASDAQ:GSIT) Q3 2024 Earnings Call Transcript (Insider Monkey)
Jan-26-24 06:03AM Q3 2024 GSI Technology Inc Earnings Call (Thomson Reuters StreetEvents) -14.93%
Jan-25-24 04:48PM GSI Technology: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yau RobertVP, Engin., Sect. & DirectorAug 30 '23Sale3.0212,50037,811927,439Aug 31 04:13 PM
Yau RobertVP, Engin., Sect. & DirectorAug 29 '23Sale3.2715,26349,855939,939Aug 31 04:13 PM
Yau RobertVP, Engin., Sect. & DirectorAug 24 '23Sale3.5018,74065,601955,202Aug 28 07:17 PM
Yau RobertVP, Engin., Sect. & DirectorAug 23 '23Sale3.503,49712,240973,942Aug 24 04:11 PM
Yau RobertVP, Engin., Sect. & DirectorAug 11 '23Sale3.254,00013,0000Aug 14 09:08 PM
CYCC - Cyclacel Pharmaceuticals Inc - Stock Price Chart
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.64MEPS (ttm)-27.02
P/E-EPS this Y64.73%
Forward P/E-EPS next Y56.23%
PEG-EPS past 5Y32.13%
P/S6.29EPS next 5Y-
P/B3.49EPS Q/Q30.27%
Dividend-Sales Q/Q-
Insider Own8.89%Inst Own7.12%
Insider Trans7.27%Inst Trans-
Short Float3.20%EarningsMar 19/a
Analyst Recom1.67Target Price11.00
Avg Volume785.72K52W Range1.30 - 13.20
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rombotis Spiro GeorgePresident and CEODec 21 '23Buy3.316,07020,12268,658Dec 26 04:05 PM
McBarron PaulSee RemarksDec 21 '23Buy3.311,8866,25233,378Dec 26 04:05 PM
BITE - Bite Acquisition Corp - Stock Price Chart
TickerBITE [AMEX]
CompanyBite Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap67.04MEPS (ttm)-0.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.76EPS Q/Q-59.52%
Dividend-Sales Q/Q-
Insider Own75.19%Inst Own25.57%
Insider Trans0.00%Inst Trans21.11%
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume28.34K52W Range6.50 - 12.81
Bite Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses for its initial business. The company was founded on September 29, 2020 and is headquartered in Chicago, IL.
ALLR - Allarity Therapeutics Inc - Stock Price Chart
TickerALLR [NASD]
CompanyAllarity Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.39MEPS (ttm)-4117.54
P/E-EPS this Y98.73%
Forward P/E-EPS next Y40.00%
PEG-EPS past 5Y57.56%
P/S-EPS next 5Y-
P/B-EPS Q/Q99.91%
Dividend-Sales Q/Q-
Insider Own10.59%Inst Own0.12%
Insider Trans0.00%Inst Trans-
Short Float4.93%EarningsMar 08/b
Analyst Recom1.00Target Price8.00
Avg Volume2.07M52W Range1.14 - 372.00
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
MRNO - Murano Global Investments PLC - Stock Price Chart
TickerMRNO [NASD]
CompanyMurano Global Investments PLC
CountryUnited Kingdom
IndustryReal Estate - Development
Market Cap77.82MEPS (ttm)0.09
P/E85.42EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.15EPS Q/Q-238.88%
Dividend-Sales Q/Q-
Insider Own85.93%Inst Own40.19%
Insider Trans0.00%Inst Trans1.59%
Short Float0.93%Earnings-
Analyst Recom-Target Price-
Avg Volume119.08K52W Range3.60 - 38.00
Murano Global Investments Plc is a real estate company, which owns, develops and invests in hotel, resort and commercial properties. It focuses on capturing value at all stages of the real estate cycle. The company is headquartered in London, the United Kingdom.
TFFP - Tff Pharmaceuticals Inc - Stock Price Chart
TickerTFFP [NASD]
CompanyTff Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap5.12MEPS (ttm)-12.68
P/E-EPS this Y54.77%
Forward P/E-EPS next Y4.66%
PEG-EPS past 5Y-13.86%
P/S-EPS next 5Y-
P/B0.50EPS Q/Q60.48%
Dividend-Sales Q/Q-
Insider Own1.74%Inst Own15.24%
Insider Trans0.00%Inst Trans11.67%
Short Float2.81%EarningsMar 28/a
Analyst Recom1.00Target Price24.50
Avg Volume34.90K52W Range2.45 - 21.25
May-01-24 05:07PM TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering (GlobeNewswire)
Apr-30-24 05:53AM TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell (MT Newswires)
Apr-29-24 08:00PM TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering (GlobeNewswire) -7.24%
10:00AM TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions (GlobeNewswire) -8.57%
Mar-28-24 10:54PM TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.35%
04:05PM TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-27-24 04:01PM TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs (GlobeNewswire)
Mar-25-24 09:01AM TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
Mar-22-24 03:11PM TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -6.33%
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARLSON CAPITAL L P10% OwnerAug 16 '23Sale0.391,0003925,064,000Aug 17 05:29 PM
Weisman Harlan FPresident and CEOAug 15 '23Buy0.25600,000150,000814,615Aug 15 08:00 AM
Mikhak ZamanehChief Medical OfficerAug 15 '23Buy0.25120,00030,000135,000Aug 15 08:00 AM
MILLS ROBERT SDirectorAug 15 '23Buy0.2540,00010,00055,980Aug 15 08:00 AM
ROCAMBOLI STEPHENDirectorAug 15 '23Buy0.2520,0005,00036,000Aug 15 08:00 AM
LLAP - Terran Orbital Corp - Stock Price Chart
TickerLLAP [NYSE, RUT]
CompanyTerran Orbital Corp
CountryUSA
IndustryAerospace & Defense
Market Cap215.36MEPS (ttm)-0.92
P/E-EPS this Y42.32%
Forward P/E-EPS next Y38.31%
PEG-EPS past 5Y-
P/S1.58EPS next 5Y28.00%
P/B-EPS Q/Q7.33%
Dividend-Sales Q/Q-1.01%
Insider Own25.63%Inst Own48.25%
Insider Trans0.00%Inst Trans11.66%
Short Float8.30%EarningsApr 01/a
Analyst Recom1.50Target Price3.10
Avg Volume3.28M52W Range0.62 - 1.95
Terran Orbital Corp. engages in the manufacture of satellite products. It operates through the Satellite Solutions and Earth Observation Solutions segments. The Satellite Solutions segment designs, builds, and operates satellites. It also includes modern facilities and global ground station network to deliver end-to-end satellite solutions, including spacecraft design, development, launch services, and on-orbit operations for critical missions across a number of applications in a variety of orbits to governmental agencies and commercial businesses. The Earth Observation Solutions segment develops constellation of company-owned Earth observation satellites featuring synthetic aperture radar capabilities to provide Earth observation data and mission solutions. The company was founded by Marc H. Bell and Anthony L. Previte in 2013 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petrocelli TobiDirectorApr 03 '24Option Exercise0.0095,1090129,275Apr 03 05:58 PM
Newton Richard Y. IIIDirectorApr 03 '24Option Exercise0.0095,1090147,479Apr 03 05:59 PM
Raaberg Douglas L.DirectorApr 03 '24Option Exercise0.0095,1090147,479Apr 03 05:58 PM
Manion Thomas E.DirectorApr 03 '24Option Exercise0.0095,1090129,275Apr 03 06:01 PM
LACHANCE JAMESDirectorApr 03 '24Option Exercise0.0095,1090430,984Apr 03 06:00 PM
KOP - Koppers Holdings Inc - Stock Price Chart
TickerKOP [NYSE, RUT]
CompanyKoppers Holdings Inc
CountryUSA
IndustrySpecialty Chemicals
Market Cap930.84MEPS (ttm)3.55
P/E12.40EPS this Y7.11%
Forward P/E8.35EPS next Y12.78%
PEG0.69EPS past 5Y30.43%
P/S0.44EPS next 5Y18.00%
P/B1.84EPS Q/Q-50.52%
Dividend0.57%Sales Q/Q-3.08%
Insider Own4.37%Inst Own92.47%
Insider Trans-22.44%Inst Trans0.37%
Short Float1.63%EarningsMay 03/b
Analyst Recom1.00Target Price65.50
Avg Volume121.44K52W Range28.45 - 58.23
Koppers Holdings, Inc. engages in the provision of treated wood products, wood treatment chemicals and carbon compounds. It operates through the following segments: Carbon Materials and Chemicals, Railroad and Utility Products and Services, and Performance Chemicals. The Carbon Materials and Chemicals segment manufactures carbon pitch naphthalene, creosote, and carbon black feedstock. The Railroad and Utility Products and Services segment sells treated and untreated wood products, manufactured products, and services primarily to the railroad and public utility markets. The Performance Chemicals segment includes development, manufacture, and marketing of wood preservation chemicals and wood treatment technologies for use in the pressure treating of lumber for residential, industrial, and agricultural applications. The company was founded in November 2004 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lucas Stephen GVP, Culture and EngagementApr 11 '24Option Exercise0.0086024,419Apr 15 04:19 PM
Hyde Leslie SSVP, Chief Sustainability OffiMar 21 '24Option Exercise22.1222,403495,50570,099Mar 22 04:39 PM
Hyde Leslie SSVP, Chief Sustainability OffiMar 21 '24Sale53.9122,4031,207,77255,658Mar 22 04:39 PM
BALL M LEROYCEOMar 06 '24Option Exercise17.575,00087,850328,080Mar 07 04:36 PM
BALL M LEROYCEOMar 06 '24Sale52.887,362389,283320,718Mar 07 04:36 PM
12345671017